SARM1 Inhibitors Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

SARM1 Inhibitors Market is segmented By Indication (Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Peripheral Neuropathies, Glaucoma) By Type of Molecule (Small Molecules, Biologics), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Million) for the above-mentioned segments.

SARM1 Inhibitors Market Leaders

  • Disarm Therapeutics
  • Nura Bio
  • Washington University
  • Asha Therapeutics
  • UCB Pharma
*Disclaimer: Major players are listed in no particular order.

SARM1 Inhibitors Market - Company List

  • Disarm Therapeutics
  • Nura Bio
  • Washington University
  • Asha Therapeutics
  • UCB Pharma